purchase customization

1 Introduction to Research & Analysis Reports
1.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Sales Channel
1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Overall Market Size
2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size: 2022 VS 2029
2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players in Global Market
3.2 Top Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies Ranked by Revenue
3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Companies
3.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Companies
3.5 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players in Global Market
3.8.1 List of Global Tier 1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Markets, 2022 & 2029
4.1.2 XIFAXAN
4.1.3 Viberzi
4.1.4 Lotronex
4.1.5 Other
4.2 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue & Forecasts
4.2.1 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2023
4.2.2 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2024-2029
4.2.3 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales & Forecasts
4.3.1 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2023
4.3.2 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2024-2029
4.3.3 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Sales Channel
5.1 Overview
5.1.1 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2022 & 2029
5.1.2 Hospitals Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue & Forecasts
5.2.1 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2023
5.2.2 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2024-2029
5.2.3 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
5.3 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales & Forecasts
5.3.1 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2023
5.3.2 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2024-2029
5.3.3 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
5.4 By Sales Channel - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2022 & 2029
6.2 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue & Forecasts
6.2.1 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2023
6.2.2 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2024-2029
6.2.3 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales & Forecasts
6.3.1 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2023
6.3.2 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2024-2029
6.3.3 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2029
6.4.2 By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2029
6.4.3 US Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.4.4 Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.4.5 Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2029
6.5.3 Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.5.4 France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.5.5 U.K. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.5.6 Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.5.7 Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.5.9 Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2029
6.6.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.6.4 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.6.5 South Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.6.7 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2029
6.7.2 By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2029
6.7.3 Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.7.4 Argentina Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2018-2029
6.8.3 Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.8.4 Israel Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
6.8.6 UAE Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bausch Health
7.1.1 Bausch Health Company Summary
7.1.2 Bausch Health Business Overview
7.1.3 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.1.4 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Bausch Health Key News & Latest Developments
7.2 Allergan
7.2.1 Allergan Company Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.2.4 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Allergan Key News & Latest Developments
7.3 Sebela Pharmaceuticals
7.3.1 Sebela Pharmaceuticals Company Summary
7.3.2 Sebela Pharmaceuticals Business Overview
7.3.3 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.3.4 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Sebela Pharmaceuticals Key News & Latest Developments
7.4 Astellas Pharmaceuticals
7.4.1 Astellas Pharmaceuticals Company Summary
7.4.2 Astellas Pharmaceuticals Business Overview
7.4.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.4.4 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Astellas Pharmaceuticals Key News & Latest Developments
7.5 Amneal Pharms
7.5.1 Amneal Pharms Company Summary
7.5.2 Amneal Pharms Business Overview
7.5.3 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.5.4 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Amneal Pharms Key News & Latest Developments
7.6 Pharscin Pharma
7.6.1 Pharscin Pharma Company Summary
7.6.2 Pharscin Pharma Business Overview
7.6.3 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.6.4 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Pharscin Pharma Key News & Latest Developments
8 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Analysis
8.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, 2018-2029
8.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Supply Chain Analysis
10.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Value Chain
10.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Upstream Market
10.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer